Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis B Cortot

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2014
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomasAlexis B Cortot, Pasi A Jänne
Oncology (Williston Park, N.Y.)|January 2, 2010
Histology... For want of anything better?Alexis B Cortot, Pasi A Jänne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2016
Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--LetterAlexis B Cortot, Denis Moro-Sibilot, Jacques Cadranel
Bulletin Du Cancer|September 20, 2016
[Osimertinib (Tagrisso<sup>®</sup>): Activity, indication and modality of use in non-small cell lung cancer]Etienne Giroux Leprieur, Alexis B Cortot, Jacques Cadranel, et al.
Oncogene|May 25, 2021
When the MET receptor kicks in to resist targeted therapiesMarie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Translational Lung Cancer Research|January 13, 2023
PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case seriesRao Mushtaq, Alexis B Cortot, Oliver Gautschi, et al.
The Oncologist|November 26, 2022
Response to Capmatinib in a MET Fusion-positive CholangiocarcinomaAnthony Turpin, Clotilde Descarpentries, Valérie Grégoire, et al.
Cancer|March 26, 2010
KRAS mutation status in primary nonsmall cell lung cancer and matched metastasesAlexis B Cortot, Antoine Italiano, Fanny Burel-Vandenbos, et al.
The American Journal of Surgical Pathology|January 19, 2017
Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung CarcinomasCamille Lapère, Alexis B Cortot, Valérie Grégoire, et al.
The European Respiratory Journal|March 23, 2013
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancerDelphine Gourcerol, Arnaud Scherpereel, Stephane Debeugny, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2014
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomasAlexis B Cortot, Pasi A Jänne
Oncology (Williston Park, N.Y.)|January 2, 2010
Histology... For want of anything better?Alexis B Cortot, Pasi A Jänne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2016
Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--LetterAlexis B Cortot, Denis Moro-Sibilot, Jacques Cadranel
Bulletin Du Cancer|September 20, 2016
[Osimertinib (Tagrisso<sup>®</sup>): Activity, indication and modality of use in non-small cell lung cancer]Etienne Giroux Leprieur, Alexis B Cortot, Jacques Cadranel, et al.
Oncogene|May 25, 2021
When the MET receptor kicks in to resist targeted therapiesMarie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Translational Lung Cancer Research|January 13, 2023
PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case seriesRao Mushtaq, Alexis B Cortot, Oliver Gautschi, et al.
The Oncologist|November 26, 2022
Response to Capmatinib in a MET Fusion-positive CholangiocarcinomaAnthony Turpin, Clotilde Descarpentries, Valérie Grégoire, et al.
Cancer|March 26, 2010
KRAS mutation status in primary nonsmall cell lung cancer and matched metastasesAlexis B Cortot, Antoine Italiano, Fanny Burel-Vandenbos, et al.
The American Journal of Surgical Pathology|January 19, 2017
Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung CarcinomasCamille Lapère, Alexis B Cortot, Valérie Grégoire, et al.
The European Respiratory Journal|March 23, 2013
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancerDelphine Gourcerol, Arnaud Scherpereel, Stephane Debeugny, et al.
Pageof 8